Bionter AG

Our first in the first family of tailored solutions for the Drug Product sector: the EVE particle counter.The revolutionary analytical testing device, supported with single-use consumables, maintenance and training services, for the biotechs drug product sector is based on a new combination light obscuration technology and smart automation.Different to the existing technologies Bionter's PC100 works non-destructive. i.e. it requires smaller sample volume which can be used for other testing thus reducing costs. Its smart automation workflow drives efficiency and minimizes human interaction and therefore improves reliability, data integrity and in turn patient safety. It also stays compliant to current regulatory requirements offering a low product entrance barrier.